Trial intelligence / Profile preview

Montelukast for Perennial Rhinitis and Sleep Disturbance

NCT00590772Phase 4Completed

Sponsor
The Pennsylvania State University
Start
May 2003
Primary completion
Jan 2009
Modality
Small Molecules
01

Overview

A Phase 4 trial of montelukast in perennial allergic rhinitis (PAR), sponsored by The Pennsylvania State University. Started May 2003; status: completed.

02

Drugs

montelukast
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00590772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00590772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call